Integrated safety and efficacy of garadacimab for hereditary angioedema prophylaxis across 3 clinical trials: phase 2, pivotal phase 3, and open- label extension studies

被引：0
|
作者：
Magerl, M. [1 ,2 ]
Craig, T. J. [3 ]
Anderson, J. [4 ]
Jacobs, J. S. [5 ]
Tachdjian, R. [6 ]
Farkas, H. [7 ]
Yang, W. H. [8 ]
Staubach, P. [9 ]
Aygoeren-Puersuen, E. [10 ]
Ohsawa, I. [11 ]
Pollen, M. [12 ]
Lawo, J. -P. [13 ]
Bica, M. A. [13 ]
Jacobs, I. [12 ]
机构：
[1] Charite Univ Med Berlin, Inst Allergol, Berlin, Germany
[2] Fraunhofer Inst Translat Med & Pharmacol ITMP Immu, Berlin, Germany
[3] Penn State Univ, Dept Med & Pediat, Allergy Asthma & Immunol, Hershey, PA USA
[4] AllerVie Clin Res, Birmingham, AL USA
[5] Allergy & Asthma Clin Res, Walnut Creek, CA USA
[6] Univ Calif Los Angeles, Div Allergy & Clin Immunol, David Geffen Sch Med, Los Angeles, CA USA
[7] Semmelweis Univ, Hungarian Angioedema Ctr Reference & Excellence, Dept Internal Med & Haematol, Budapest, Hungary
[8] Univ Ottawa, Ottawa Allergy Res Corp, Ottawa, ON, Canada
[9] Univ Med Ctr Mainz, Dept Dermatol & Allergy, Mainz, Germany
[10] Univ Hosp Frankfurt, Dept Children & Adolescents, Frankfurt, Germany
[11] Saiyu Soka Hosp, Dept Nephrol, Saitama, Japan
[12] CSL Behring, King Of Prussia, PA USA
[13] CSL Behring Innovat GmbH, Marburg, Germany
来源：
ALLERGOLOGIE | 2024年 / 47卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P2.9
引用
收藏
页数：55
相关论文
共 50 条
  • [21] Efficacy, pharmacokinetics, and safety of icatibant for the treatment of Japanese patients with an acute attack of hereditary angioedema: A phase 3 open-label study
    Hide, Michihiro
    Fukunaga, Atsushi
    Maehara, Junichi
    Eto, Kazunori
    Hao, James
    Vardi, Moshe
    Nomoto, Yuji
    ALLERGOLOGY INTERNATIONAL, 2020, 69 (02) : 268 - 273
  • [22] PHASE 2 OPEN-LABEL EXTENSION OF DONIDALORSEN IN PATIENTS WITH HEREDITARY ANGIOEDEMA: A WEEK 197 ANALYSIS
    Manning, M.
    Bordone, L.
    Cohn, D.
    Deng, Y.
    Treadwell, S.
    Newman, K.
    Riedl, M.
    Tachdjian, R.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (06) : S38 - S38
  • [23] Garadacimab prophylaxis improves quality of life in adult and adolescent patients with hereditary angioedema: Results from a multicentre Phase 3 study
    Lumry, W.
    Magerl, M.
    Craig, T. J.
    Farkas, H.
    Yang, W.
    Stroes, E. S.
    Saguer, I. Martinez
    Aygoeren-Puersuen, E.
    Staubach, P.
    Treudler, R.
    Itzler, R.
    Feuersenger, H.
    Pragst, I.
    Reshef, A.
    ALLERGY, 2023, 78 : 114 - 115
  • [24] Icatibant for the treatment of repeated attacks of hereditary angioedema: FAST-3 trial open-label extension study phase
    Lumry, W.
    Levy, R.
    Li, H.
    Farkas, H.
    ALLERGY, 2013, 68 : 254 - 255
  • [25] Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial
    Levy, Donald S.
    Farkas, Henriette
    Riedl, Marc A.
    Hsu, Florence Ida
    Brooks, Joel P.
    Cicardi, Marco
    Feuersenger, Henrike
    Pragst, Ingo
    Reshef, Avner
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2020, 16 (01):
  • [26] Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial
    Donald S. Levy
    Henriette Farkas
    Marc A. Riedl
    Florence Ida Hsu
    Joel P. Brooks
    Marco Cicardi
    Henrike Feuersenger
    Ingo Pragst
    Avner Reshef
    Allergy, Asthma & Clinical Immunology, 16
  • [27] Phase 2 Open-Label Extension Study With Donidalorsen Treatment in Patients With Hereditary Angioedema: Pharmacodynamic Data
    Tayefeh, Leighla
    Riedl, Marc
    Bordone, Laura
    Newman, Kenneth
    Lui, Cindy
    Alexander, Veronica
    Cohn, Danny
    Schneider, Eugene
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB129 - AB129
  • [28] Telotristat Ethyl in Carcinoid Syndrome: Safety and Efficacy Results of an Open-Label Extension of the TELECAST Phase 3 Clinical Trial
    Pavel, Marianne
    Benavent, Marta
    Perros, Petros
    Srirajaskanthan, Raj
    Warner, Richard R. P.
    Kulke, Matthew H.
    Anthony, Lowell B.
    Kunz, Pamela L.
    Hoersch, Dieter
    Lapuerta, Pablo
    Fleming, Rosanna
    Gross, David J.
    PANCREAS, 2018, 47 (03) : 350 - 350
  • [29] Telotristat Ethyl in Carcinoid Syndrome: Safety and Efficacy Results of an Open-Label Extension of the TELECAST Phase 3 Clinical Trial
    Pavel, M.
    Benavent, M.
    Perros, P.
    Srirajaskanthan, R.
    Warner, R. R. P.
    Kulke, M. H.
    Anthony, L. B.
    Kunz, P.
    Hoersch, D.
    Lapuerta, P.
    Fleming, R.
    Gross, D.
    NEUROENDOCRINOLOGY, 2017, 105 : 205 - 205
  • [30] LONG-TERM SAFETY AND EFFICACY OF ORAL DEUCRICTIBANT FOR HEREDITARY ANGIOEDEMA PROPHYLAXIS: CHAPTER-1 OPEN-LABEL EXTENSION STUDY
    Anderson, J.
    Chapdelaine, H.
    Magerl, M.
    Manning, M.
    Riedl, M.
    Wedner, H.
    Lu, P.
    Aygoren-Pursun, E.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (06) : S35 - S35
12345